中华麻醉学杂志
中華痳醉學雜誌
중화마취학잡지
CHINESE JOURNAL OF ANESTHESIOLOGY
2015年
2期
165-167
,共3页
原峰%李宁%孙申%聂玉艳%耿桂启%黄绍强
原峰%李寧%孫申%聶玉豔%耿桂啟%黃紹彊
원봉%리저%손신%섭옥염%경계계%황소강
右美托咪啶%寒战%麻醉,脊椎%麻醉,硬膜外
右美託咪啶%寒戰%痳醉,脊椎%痳醉,硬膜外
우미탁미정%한전%마취,척추%마취,경막외
Dexmedetomidine%Shivering%Anesthesia,spinal%Anesthesia,epidural
目的 评价不同剂量右美托咪定预防剖官产术患者脊椎-硬膜外麻醉后寒战的效果.方法 选择脊椎-硬膜外麻醉下行剖宫产术患者120例,ASA分级Ⅰ或Ⅱ级,年龄20 ~ 40岁,体重指数≤35 kg/m2,采用随机数字表法,将其分为4组(n=30):对照组(C组)和右美托咪定0.1、0.3和0.5 μg/kg组(D1组、D2组和D3组).于L34间隙行脊椎-硬膜外穿刺,于蛛网膜下腔注入等比重0.5%布比卡因2 ml.于夹闭脐带后D1组、D2组和D3组分别静脉输注右美托咪定0.1、0.3和0.5 μg/kg(溶于50 ml生理盐水中),C组输注生理盐水50 ml,输注速率均为5 ml/min.记录右美托咪定输注结束后至出PACU期间寒战、心动过缓、低血压和恶心呕吐的发生情况.结果 与C组比较,D2组和D3组寒战发生率、寒战程度和恶心呕吐发生率降低(P<0.05),D1组上述各指标差异无统计学意义(P>0.05);与D2组比较,D3组寒战发生率、寒战程度和恶心呕吐发生率降低(P<0.05).结论 右美托咪定0.3和0.5 μg/kg可预防剖宫产术患者脊椎-硬膜外麻醉后寒战的发生,其中0.5 μg/kg效果更佳.
目的 評價不同劑量右美託咪定預防剖官產術患者脊椎-硬膜外痳醉後寒戰的效果.方法 選擇脊椎-硬膜外痳醉下行剖宮產術患者120例,ASA分級Ⅰ或Ⅱ級,年齡20 ~ 40歲,體重指數≤35 kg/m2,採用隨機數字錶法,將其分為4組(n=30):對照組(C組)和右美託咪定0.1、0.3和0.5 μg/kg組(D1組、D2組和D3組).于L34間隙行脊椎-硬膜外穿刺,于蛛網膜下腔註入等比重0.5%佈比卡因2 ml.于夾閉臍帶後D1組、D2組和D3組分彆靜脈輸註右美託咪定0.1、0.3和0.5 μg/kg(溶于50 ml生理鹽水中),C組輸註生理鹽水50 ml,輸註速率均為5 ml/min.記錄右美託咪定輸註結束後至齣PACU期間寒戰、心動過緩、低血壓和噁心嘔吐的髮生情況.結果 與C組比較,D2組和D3組寒戰髮生率、寒戰程度和噁心嘔吐髮生率降低(P<0.05),D1組上述各指標差異無統計學意義(P>0.05);與D2組比較,D3組寒戰髮生率、寒戰程度和噁心嘔吐髮生率降低(P<0.05).結論 右美託咪定0.3和0.5 μg/kg可預防剖宮產術患者脊椎-硬膜外痳醉後寒戰的髮生,其中0.5 μg/kg效果更佳.
목적 평개불동제량우미탁미정예방부관산술환자척추-경막외마취후한전적효과.방법 선택척추-경막외마취하행부궁산술환자120례,ASA분급Ⅰ혹Ⅱ급,년령20 ~ 40세,체중지수≤35 kg/m2,채용수궤수자표법,장기분위4조(n=30):대조조(C조)화우미탁미정0.1、0.3화0.5 μg/kg조(D1조、D2조화D3조).우L34간극행척추-경막외천자,우주망막하강주입등비중0.5%포비잡인2 ml.우협폐제대후D1조、D2조화D3조분별정맥수주우미탁미정0.1、0.3화0.5 μg/kg(용우50 ml생리염수중),C조수주생리염수50 ml,수주속솔균위5 ml/min.기록우미탁미정수주결속후지출PACU기간한전、심동과완、저혈압화악심구토적발생정황.결과 여C조비교,D2조화D3조한전발생솔、한전정도화악심구토발생솔강저(P<0.05),D1조상술각지표차이무통계학의의(P>0.05);여D2조비교,D3조한전발생솔、한전정도화악심구토발생솔강저(P<0.05).결론 우미탁미정0.3화0.5 μg/kg가예방부궁산술환자척추-경막외마취후한전적발생,기중0.5 μg/kg효과경가.
Objective To evaluate the efficacy of different doses of dexmedetomidine for prevention of shivering after combined spinal-epidural anesthesia in the patients undergoing caesarean section.Methods A total of 120 patients,of ASA physical status Ⅱ or Ⅱ,aged 20-40 yr,with body mass index≤ 35 kg/m2,scheduled for elective caesarean section under combined spinal-epidural anesthesia,were randomly divided into 4 groups (n =30 each) using a random number table:control group (group C) and dexmedetomidine 0.1,0.3 and 0.5 μg/kg groups (D1,D2 and D3 groups).Combined spinal-epidural anesthesia was performed at L3,4 interspace with isobaric 0.5% bupivacaine 2 ml.In D1,D2 and D3 groups,dexmedetomidine 0.1,0.3 and 0.5 μg/kg (in 50 ml of normal saline) were infused intravenously,respectively.In group C,normal saline 50 ml was infused at a rate of 5 ml/min.The development of shivering,bradycardia,hypotension,nausea and vomiting was recorded during the period from the end of dexmedetomidine infusion to PACU discharge time.Results Compared with group C,the incidence and degree of shivering and incidence of nausea and vomiting were significantly decreased in D2 and D3 groups,and no significant change was found in the parameters mentioned above in group D1.Compared with group D2,the incidence and degree of shivering and incidence of nausea and vomiting were significantly decreased in D3 group.Conclusion Dexmedetomidine 0.3 and 0.5 μg/kg can prevent shivering after combined spinal-epidural anesthesia in the patients undergoing caesarean section,and 0.5 μg/kg provides better efficacy.